Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TX1S
|
|||
| Drug Name |
PMID25656651-Compound-33a
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
PF MEDICAMENT [FR]
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H31F2N7O2S
|
|||
| Canonical SMILES |
CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=C4C=C(C=NC4=NN3)SC5=CC(=CC(=C5)F)F)NC6CCOCC6
|
|||
| InChI |
1S/C29H31F2N7O2S/c1-37-6-8-38(9-7-37)21-2-3-24(26(15-21)33-20-4-10-40-11-5-20)29(39)34-28-25-16-23(17-32-27(25)35-36-28)41-22-13-18(30)12-19(31)14-22/h2-3,12-17,20,33H,4-11H2,1H3,(H2,32,34,35,36,39)
|
|||
| InChIKey |
DNSGDBHRFQIANM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.